Holen Sie sich die Stockscreener-App
11.54
1.54%
0.14
Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
18.97%
3.289
|
4.059 | 5.3275 | 5.1308 | 4.9011 |
| Interest Income/Expense |
0.00971
|
- | - | - | - |
| Operating Income/Loss |
18.97%
-3.289
|
-4.059 | -5.3275 | -5.1308 | -4.9011 |
| Nonoperating Income/Loss |
32.68%
-0.0378
|
-0.0285 | 0.0276 | 0.7892 | 0.0842 |
| Income/Loss From Continuing Operations Before Tax |
18.61%
-3.3268
|
-4.0875 | -5.30 | -4.3417 | -4.8169 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
18.61%
-3.3268
|
-4.0875 | -5.30 | -4.3417 | -4.8169 |
|
Net Income/Loss
|
18.61%
-3.3268
|
-4.0875 | -5.30 | -4.3417 | -4.8169 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
436.13%
5.1424
|
-1.5299 | 3.1572 | 1.3195 | 14.40 |
| Diluted Average Shares |
436.13%
5.1424
|
-1.5299 | 3.1572 | 1.3195 | 14.40 |
| Basic Earnings Per Share |
99.32%
-0.65
|
-95.15 | -1.68 | -3.29 | -0.33 |
| Diluted Earnings Per Share |
99.32%
-0.65
|
-95.15 | -1.68 | -3.29 | -0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.17%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):